Compugen to Participate in H.C. Wainwright Global Investment Conference Fireside Chat.

Compugen Ltd., a clinical-stage cancer immunotherapy company, announced that management will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference. The chat will be available on-demand on the company's website from September 5, 2025, for 90 days. Compugen is developing two proprietary product candidates, COM701 and COM902, for cancer immunotherapies.

Compugen Ltd., a clinical-stage cancer immunotherapy company, has announced that management will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference. The event, scheduled to take place on September 5, 2025, will be available on-demand on the company's website from the same date for 90 days [1].

The fireside chat will provide investors and financial professionals with an opportunity to gain insights into Compugen's pipeline and strategic direction. The company is developing two proprietary product candidates, COM701 and COM902, which are in Phase 1 development for cancer immunotherapies. COM701 is a potential first-in-class anti-PVRIG antibody, while COM902 is a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors [2].

In addition to these product candidates, Compugen's therapeutic pipeline includes early-stage immuno-oncology programs aimed at addressing new mechanisms to activate the immune system against cancer. The company is also involved in the development of bispecific and multispecific antibodies, with Rilvegostomig, a PD-1/TIGIT bispecific antibody derived from COM902, currently in Phase 3 development by AstraZeneca [2].

Compugen's shares are listed on the Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. For further information, interested parties can contact Yvonne Naughton, Ph.D., Vice President, Head of Investor Relations and Corporate Communications, at ir@cgen.com or +1 (628) 241-0071.

References:
[1] https://www.marketscreener.com/news/compugen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference-ce7c50dfde8af126
[2] https://finance.yahoo.com/news/compugen-present-h-c-wainwright-110000478.html